New Prostate Cancer Surgery Technique Doubles Chance of Preserving Erectile Function
The NeuroSafe method offers real-time nerve-sparing during surgery, improving quality of life without compromising cancer control, but faces scalability challenges in the NHS.
- The NeuroSafe technique nearly doubles the likelihood of retaining erectile function after prostate cancer surgery compared to standard methods.
- This procedure involves real-time analysis of prostate tissue during surgery to determine if nerves can be preserved while ensuring cancer removal.
- A trial of 344 men found that 39% of those undergoing NeuroSafe had no or mild erectile dysfunction after one year, compared to 23% with standard surgery.
- The method is particularly beneficial for younger patients and those previously ineligible for nerve-sparing surgery, though it may not be suitable for all cases.
- Experts highlight the need for further research to confirm long-term efficacy and scalability across the NHS due to the procedure’s complexity and reliance on specialized pathology support.